Endocrine-related Cancer

Journal Title：Endocrine-related Cancer

Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society.

Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.

Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.

《内分泌相关癌症》是内分泌学会的官方旗舰期刊，并得到欧洲内分泌学会、英国和爱尔兰神经内分泌学会以及日本激素和癌症学会的认可。

《内分泌相关癌症》提供了一个独特的国际论坛，用于发表高质量的原创文章，描述以内分泌肿瘤和激素依赖性癌症为重点的人类健康和疾病的新颖、前沿的基础实验室、转化和临床研究；并发表这些主题的权威评论文章。

内分泌肿瘤包括肾上腺皮质、乳腺癌、多发性内分泌肿瘤、神经内分泌肿瘤、卵巢、前列腺、副神经节瘤、甲状旁腺、垂体嗜铬细胞瘤、睾丸、甲状腺和激素依赖性癌症。还考虑影响新陈代谢和能量产生的肿瘤，如膀胱、骨骼、肾脏、肺和头颈部。

Endocrine-related Cancer创刊于1994年，由BioScientifica Ltd.出版商出版，收稿方向涵盖内分泌学与代谢 - 医学全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 较慢,6-12周 ，影响因子指数4.1，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。